The healthcare industry is no stranger to technological advancements, and artificial intelligence (AI) is quickly becoming a game-changer in multiple areas. From diagnosing medical conditions to ...
A licensed attorney with nearly a decade of experience in content production, Valerie Catalano knows how to help readers digest complicated information about the law ...
What's CODE SWITCH? It's the fearless conversations about race that you've been waiting for. Hosted by journalists of color, our podcast tackles the subject of race with empathy and humor. We explore ...
Xtant Medical Holdings, Inc. provides regenerative medicine products and medical devices for orthopedic and neurological surgeons in the United States and internationally. It offers OsteoSponge, a ...
Used in complex experiments in conjunction with our other micromanipulators, or as a stand alone unit in a teaching environment, the MM-33 is available separately for those wishing a small, practical ...
A new study led by a team from the University of Ottawa takes a major step forward in understanding how a heart attack can dramatically reshape brain function and trigger neurological effects, from ...
Health news moves fast, with new studies, findings, and regulatory updates changing the landscape daily. Insights from advocates and celebrities can also impact the public awareness of certain health ...
The FDA approved datopotamab deruxtecan-dlnk as the first TROP2-directed antibody drug conjugate for first-line treatment of unresectable or metastatic triple-negative breast cancer in patients ...
The Medical News Today news team reports on emerging science, cutting-edge research, new treatments, and trending topics in health and medicine. All articles are written by our network of editors and ...
Three more digoxin trials, yet another GLP-1 drug on the horizon, vagal nerve stimulation, trial inside baseball, and more on lipid guidelines are the topics John Mandrola, MD, discusses in this ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results